Perfluoroundecanoic acid (PFUnA)

The chemicals in this family are built to last. Once they get into your body, some linger for years, and this one is among the more stubborn of them. Checking your level is a way to gauge how much of this persistent pollution you are carrying.

There is a catch worth stating up front. For this specific compound, a urine sample is a weaker window than blood, so a single urine number is best read as a rough exposure signal rather than a precise measure of what is stored in your body.

What This Chemical Actually Is

PFUnA (perfluoroundecanoic acid), often written PFUnDA in research papers, is an eleven-carbon, long-chain member of a large group of manufactured coatings and surfactants known collectively as PFAS (per- and polyfluoroalkyl substances, the forever chemicals). It belongs to a subgroup called perfluoroalkyl carboxylic acids, which are ranked by how many carbon atoms sit in their fluorinated backbone.

Your body does not make this molecule. There is no gland, organ, or cell that produces it, because it is entirely synthetic and enters only through the environment. Among these chemicals, the longer-chain versions like this one tend to stay in the body far longer than the shorter ones, which is part of why they draw attention in toxicology.

Why Blood Studies, Not Urine, Carry the Health Signal

Almost everything known about how this compound relates to human health comes from studies that measured it in blood serum or plasma, not urine. That matters for interpretation: the disease associations below describe people whose blood levels were measured, which is a related but different measurement than the urine value this test reports.

The associations are also mostly observational and mixed. They describe patterns across populations, not proof that this one chemical causes any given condition, and several of the findings point in surprising directions that are explained further down.

Cholesterol and Heart Findings

In a study of Norwegian adolescents, higher blood levels of this chemical were linked to higher total cholesterol, higher LDL cholesterol (the kind that drives artery plaque), and higher ApoB (apolipoprotein B, a count of the particles that carry cholesterol into artery walls). A separate systematic review of lipid studies found the same broad pattern for total and LDL cholesterol across many PFAS.

In a large United States survey, higher blood levels of this compound were associated with more coronary heart disease and angina, though that was a snapshot in time and cannot show cause. The relationship is not simple: some newer national analyses have found the opposite, with several PFAS linked to lower cardiovascular risk, and this chemical has trended toward lower triglycerides (a different blood fat) in some studies. Its relationship with blood fats is not uniformly in one direction.

Pregnancy Risks

Pregnancy is where the concern is most consistent. In a nested case-control study in China, higher early-pregnancy blood levels of this chemical were positively associated with high blood pressure disorders of pregnancy. A newer Chinese study identified it as one of the main contributors, alongside two related compounds, to a mixture linked with preterm birth.

A cohort in the United States found that each step up across the middle range of exposure carried roughly 77% higher odds of one type of preterm birth. Set against that, a large pooled analysis of pregnancy studies reported limited overall evidence and even an inverse link between this compound and preeclampsia, and one cohort found it associated with lower odds of gestational hypertension, so the pregnancy picture is not settled.

Autoimmune Disease

In a Chinese case-control study, people in the highest quarter of blood levels of this chemical had about 2.8 times the odds of systemic lupus erythematosus (an autoimmune disease in which the immune system attacks the body's own tissues) compared with those in the lowest quarter, and the risk climbed steadily across increasing exposure. This is a single study of blood levels and should be read as a signal, not a verdict.

Thyroid and Puberty

In adolescents, higher blood levels of this compound were linked to lower free thyroxine and free triiodothyronine in boys, the two active thyroid hormones that set metabolic pace. In the same cohort, higher levels tracked with earlier first menstruation in girls. The thyroid findings are not consistent, though: a Spanish cohort found the opposite direction, with higher levels linked to more free thyroxine in adolescent boys. These are hormone associations from separate populations and do not establish that the chemical drives thyroid disease.

Why the Numbers Point in Different Directions

Some findings look backwards at first glance. In one long-term study, higher blood levels of this chemical were associated with better kidney filtration, and in a couple of child studies higher levels tracked with lower odds of autism or eczema. Read literally, that would suggest the chemical is protective, which the study authors explicitly reject.

The resolution is that this is not a simple higher-is-worse marker. It is an exposure indicator, and the way your body handles it can bend the numbers. Because kidney function influences how efficiently the body clears and reabsorbs these chemicals, people with better kidney function can end up with lower blood levels, which can make healthier organs look artificially linked to lower exposure. Those inverse results most likely reflect this tangle and leftover confounding, not a real benefit.

Why Urine Can Mislead You Here

This is the single most important thing to understand about the test. In paired blood and urine samples from Chinese adults, this compound was found in urine 98% of the time at a median of 0.30 nanograms per liter (a very small concentration), yet it was the only measured chemical in its family whose urine level did not track its blood level. In other words, your urine value may not reflect how much is actually stored in your body.

The biology behind this is that short-chain versions of these chemicals leave mainly through urine, but longer-chain ones like this one are cleared substantially through other routes, most likely the stool. A 2025 review concluded that urine is not the most appropriate sample for these longer chemicals. That does not make the urine test useless, but it does mean a low urine reading cannot rule out a meaningful body burden.

Tracking Your Trend

These chemicals are not metabolized and clear slowly, so levels shift over years, not days. In a study measuring blood plasma (a related but different sample than this urine test), the median level of this compound rose from 0.28 to 0.44 and settled at 0.36 nanograms per milliliter across ten years in the same older adults, an overall increase of about 26%. Trends vary by region and era, though: after manufacturing phase-outs, some cohorts have shown levels falling by several percent a year. That persistence is exactly why one reading tells you little on its own.

The value comes from a trajectory. Get a baseline, and if you are deliberately cutting exposure, retest in 6 to 12 months to see whether the direction is moving, keeping in mind that meaningful change can take longer given how slowly these chemicals clear, then at least annually. Because this is an exploratory marker without standardized cutpoints, pair urine testing with a blood PFAS panel when you want a firmer read, since blood is the better-validated window for this particular compound.

What an Unexpected Result Should Prompt

A single urine number should not drive a decision by itself. If your result is higher than you expected, the most useful next step is a serum PFAS panel that measures this chemical and its relatives directly in blood, which is the matrix the health studies actually used. That combination tells you far more than either test alone.

Alongside that, it is reasonable to order kidney filtration markers such as cystatin C and creatinine-based estimates, because kidney function shapes how these chemicals are cleared and can distort the readings. If exposure looks high, review your likely sources with a clinician or environmental health specialist, and consider companion checks that map to the associations above: a lipid panel with ApoB, and thyroid hormones if symptoms warrant. The pattern across several tests, not one urine value, is what should guide action.

When Results Can Be Misleading

• Kidney function: because kidney function affects how efficiently these chemicals are cleared and reabsorbed, reduced filtration can shift measured concentrations, so a result can reflect how your kidneys are handling the chemical as much as how much you were exposed to.
• Poor urine-to-blood match: this specific compound was the exception among its family, with urine levels that did not correlate with blood, so a low urine value does not reliably mean a low body burden.
• Non-urinary elimination: longer-chain chemicals like this one are cleared substantially through routes other than urine, most likely the stool, which further weakens urine as a stand-alone measure of internal dose.
• Urine dilution: how concentrated or dilute your urine is at collection can nudge a spot value up or down independent of true exposure.